June 2007 Issue - Endovascular Today

Table of Contents

Issue

June 2007

In This Issue

Chief Medical Editor's Page

Addressing Unanswered Questions

By Takao Ohki, MD, PhD, Chief Medical Editor

Coding And Reimbursement

Percutaneous Renal Revascularization and Medicare Coverage

The Society of Interventional Radiology's position on the current CMS coverage of renal interventions.

By David Sacks, MD, and Timothy P. Murphy, MD

Challenging Cases

A Combination Approach to Mesenteric Venous Thrombosis

Using percutaneous transhepatic thrombectomy and pharmacological thrombolysis to treat this highly morbid condition.

By Wei Zhou, MD; Tam T. Huynh, MD; and Peter H. Lin, MD

Techniques

Excimer Laser as an Adjunct for Popliteal Aneurysms

A case report demonstrating the use of this novel technique.

By Mark W. Moritz, MD, FACS, and Michael Ombrellino, MD, FACS

Cover Story

What Is the Correct Endpoint?

Discerning endpoints for clinical trials in endovascular therapy for infrainguinal arterial disease.

By Michael R. Jaff, DO

TASC II 2007: What Has Changed?

An interview with TASC II Co-Chair Lars Norgren, MD, PhD, FRCS, regarding the recently updated and published recommendations.

By TASC II Co-Chair Lars Norgren, MD, PhD, FRCS

Setting the Stage for Future Lower-Extremity Device Trials

Krishna Rocha-Singh, MD, of VIVA Physicians, Inc., discusses their effort to determine nitinol stenting performance goals, collaboration with the FDA and industry, and how clinicians can apply these standards to their practices.

By Krishna Rocha-Singh, MD

Why Are There So Few Vascular Stents Approved?

An interview with Jennifer Goode of the FDA.

By Jennifer Goode

SFA Stenting Studies Update

Embolic Protection Questions Answered

What is the embolic risk for endovascular SFA intervention? When is embolic protection necessary?

By Michael Wholey, MD, MBA; William C.L. Wu, MD; Boulos Toursarkissian, MD; Raj Suri, MD; Marco Cura, MD; and Martin G. Radvany, MD

Drug-Eluting Stents in the Periphery

A summary of the barriers, unanswered questions, and potential benefits of this technology.

By H. Bob Smouse, MD

An Interview with Ted E. Feldman, MD

A leader in structural heart repair discusses cardiologists' increased role in the periphery, his multidisciplinary practice, and the EVEREST trial.

By Ted E. Feldman, MD

Innovations

Latest Issues

March 2026

February 2026

January 2026

December 2025

November 2025

View All Issues

In This Issue

Most Read Articles